Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 0.9% NaCl on incidence of hyperchloremic metabolic acidosis
TCTR20200703004Phase 3Completed
- Start
- Nov 2015
- Countries
- 1
01
Overview
A Phase 3 trial of sodium chloride in hyperchloremic acidosis (NAGMA), sponsored by None. Started Nov 2015; status: completed.
02
Drugs
sodium chloride
03
Conditions
hyperchloremic acidosis (NAGMA)
Beyond the preview
Go deeper on TCTR20200703004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200703004.